Showing results (351-360 of 584) with videos related to

Sort By:
Pageof 59
Chest|October 21, 2005
Formoterol attenuates neutrophilic airway inflammation in asthmaKittipong Maneechotesuwan, Sarah Essilfie-Quaye, Sally Meah, et al.
Respirology (Carlton, Vic.)|April 15, 2015
Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?Wei Gao, Lingling Li, Yujie Wang, et al.
Chest|October 11, 2007
CXCR3 and CCR5 chemokines in induced sputum from patients with COPDClaudia Costa, Rogerio Rufino, Suzanne L Traves, et al.
BMC Pulmonary Medicine|December 23, 2011
Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trialBrian J O'Connor, Sara Collarini, Gianluigi Poli, et al.
American Journal of Respiratory and Critical Care Medicine|April 15, 2006
Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthmaMark Hew, Pankaj Bhavsar, Alfons Torrego, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2004
Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthmaBorja G Cosío, Buphinder Mann, Kazuhiro Ito, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 4, 2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysisMario Cazzola, Luigino Calzetta, Peter J Barnes, et al.
European Journal of Pharmacology|September 17, 2011
Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cellsChristos Rossios, Yasuo To, Masako To, et al.
Expert Opinion on Drug Discovery|February 12, 2025
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical reviewMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinionLizza E L Hendriks, Christophe Dooms, Thierry Berghmans, et al.
Pageof 59